tiprankstipranks
Trending News
More News >
OncoArendi Therapeutics SA (DE:1B1)
FRANKFURT:1B1
Germany Market
Advertisement

OncoArendi Therapeutics SA (1B1) Cash flow

Compare
0 Followers

OncoArendi Therapeutics SA Cash Flow

DE:1B1's free cash flow for Q1 2025 was zł22.41M. For the 2025 fiscal year, DE:1B1's free cash flow was decreased by zł-24.38M and operating cash flow was zł26.15M. See a summary of the company’s cash flow.
Cash Flow
Dec 24Dec 23Dec 22Dec 21Dec 20
Operating Cash Flow
zł -56.99Mzł -23.29Mzł -10.21Mzł -13.50Mzł 57.44M
Investing Cash Flow
zł -23.57Mzł -33.87Mzł -33.59Mzł -18.82Mzł 8.58M
Financing Cash Flow
zł 34.76Mzł 55.53Mzł 7.38Mzł 13.86Mzł 20.45M
End Cash Position
zł 18.19Mzł 63.99Mzł 65.62Mzł 102.04Mzł 120.50M
Free Cash Flow
zł -80.76Mzł -56.38Mzł -43.84Mzł -32.33Mzł 55.35M
Currency in PLN

OncoArendi Therapeutics SA Cash Flow

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis